Gå till forskningen.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för pioglitazone. Visa hela publikationsregistret

En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publikationer i urvalet

12 träffar

Bibliografisk träff 2021-05-19

Pioglitazone prevents obesity-related airway hyperreactivity and neuronal M<sub>2</sub> receptor dysfunction.

Proskocil BJ, Fryer AD, Jacoby DB, Nie Z.

Am J Physiol Lung Cell Mol Physiol · research-article; journal article; research support, n.i.h., extramural · DOI 10.1152/ajplung.00567.2020

Bibliografisk träff 2021-05-18

Rethinking pioglitazone as a cardioprotective agent: a new perspective on an overlooked drug.

Nesti L, Tricò D, Mengozzi A, Natali A.

Cardiovasc Diabetol · review-article; review; journal article · DOI 10.1186/s12933-021-01294-7

Bibliografisk träff 2021-05-13

Therapeutic effects of an aspalathin-rich green rooibos extract, pioglitazone and atorvastatin combination therapy in diabetic db/db mice.

Patel O, Muller CJF, Joubert E, Rosenkranz B, Louw J, Awortwe C.

PLoS One · research support, non-u.s. gov't; research-article; journal article · DOI 10.1371/journal.pone.0251069

Bibliografisk träff 2021-04-28

Pioglitazone for NAFLD Patients With Prediabetes or Type 2 Diabetes Mellitus: A Meta-Analysis.

Lian J, Fu J.

Front Endocrinol (Lausanne) · meta-analysis; research support, non-u.s. gov't; systematic review; systematic-review; journal article · DOI 10.3389/fendo.2021.615409

Bibliografisk träff 2021-04-16

Neuroprotective and antioxidative effects of pioglitazone in brain tissue adjacent to the ischemic core are mediated by PI3K/Akt and Nrf2/ARE pathways.

Zhao Y, Lützen U, Gohlke P, Jiang P, Herdegen T, Culman J.

J Mol Med (Berl) · research support, non-u.s. gov't; research-article; journal article · DOI 10.1007/s00109-021-02065-3

Bibliografisk träff 2021-03-31

Effects of SGLT2 inhibitor ipragliflozin alone and combined with pioglitazone on fluid retention in type 2 diabetic mice with NASH.

Tahara A.

Eur J Pharmacol · journal article · DOI 10.1016/j.ejphar.2021.174076

Bibliografisk träff 2016-11-14

ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition.

Doll S, Proneth B, Tyurina YY, Panzilius E, Kobayashi S, Ingold I, Irmler M, Beckers J, Aichler M, Walch A, Prokisch H, Trümbach D, Mao G, Qu F, Bayir H, Füllekrug J, Scheel CH, Wurst W, Schick JA, Kagan VE, Angeli JP, Conrad M.

Nat Chem Biol · research-article; journal article · DOI 10.1038/nchembio.2239

Bibliografisk träff 2010-08-01

Modulation of pantothenate kinase 3 activity by small molecules that interact with the substrate/allosteric regulatory domain.

Leonardi R, Zhang YM, Yun MK, Zhou R, Zeng FY, Lin W, Cui J, Chen T, Rock CO, White SW, Jackowski S.

Chem Biol · research support, non-u.s. gov't; research-article; journal article; research support, n.i.h., extramural · DOI 10.1016/j.chembiol.2010.06.006

Bibliografisk träff 2008-01-01

PPARgamma agonist pioglitazone reduces [corrected] neuronal cell damage after transient global cerebral ischemia through matrix metalloproteinase inhibition.

Lee KJ, Jang YH, Lee H, Yoo HS, Lee SR.

Eur J Neurosci · comparative study; research support, non-u.s. gov't; journal article · DOI 10.1111/j.1460-9568.2007.06007.x

Bibliografisk träff 2007-07-13

Pioglitazone: an anti-diabetic compound with anti-aging properties.

Jafari M, Khodayari B, Felgner J, Bussel II, Rose MR, Mueller LD.

Biogerontology · journal article · DOI 10.1007/s10522-007-9105-7

Bibliografisk träff 2003-09-01

Sex differences in the pharmacokinetics of pioglitazone in rats.

Fujita Y, Yamada Y, Kusama M, Yamauchi T, Kamon J, Kadowaki T, Iga T.

Comp Biochem Physiol C Toxicol Pharmacol · journal article · DOI 10.1016/s1532-0456(03)00194-7

Bibliografisk träff 2003-07-01

Cardioprotection with pioglitazone is abolished by nitric oxide synthase inhibitor in ischemic rabbit hearts--comparison of the effects of pioglitazone and metformin.

Kawabata H, Ishikawa K.

Diabetes Metab Res Rev · comparative study; journal article · DOI 10.1002/dmrr.379